The Lancet Psychiatry
-
ADHD, amphetamines, atomoxetine, bupropion, clonidine, dexmethylphenidate, guanfacine, medication, medication safety, medicines, meta-analysis, methylphenidate, modafinil, network meta-analysis, neurodiversity, pharmacological intervention, psychopharmacology, Stimulants, systematic review, The Lancet Psychiatry, therapeutic inertia, viloxazineThe Goldilocks zone: getting ADHD medication ‘just right’
Neurodivergence, including Attention Deficit-Hyperactivity Disorder (ADHD), remains an area of great interest…
-
ADHD, amphetamines, atomoxetine, bupropion, clonidine, dexmethylphenidate, guanfacine, medication, medication safety, medicines, meta-analysis, methylphenidate, modafinil, network meta-analysis, neurodiversity, pharmacological intervention, psychopharmacology, Stimulants, systematic review, The Lancet Psychiatry, therapeutic inertia, viloxazineThe Goldilocks zone: getting ADHD medication ‘just right’
Neurodivergence, including Attention Deficit-Hyperactivity Disorder (ADHD), remains an area of great interest…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotics, cardiometabolic health, cardiovascular disease, cardiovascular screening, clinical prediction model, cohort study, early intervention in psychosis, Editor Eimear Foley, metabolic syndrome, mixed methods, mortality gap, obesity, personalised care, precision psychiatry, prediction, preventive healthcare, psychosis, risk factors, risk prediction, schizophrenia, severe mental illness, shared decision making, The Lancet Psychiatry, type 2 diabetes, weight gainPsychosis and metabolic risk: PsyMetRiC 2.0 reaches the clinic
Compared to the general population, individuals with psychosis have a 15-year reduced…
-
brief intervention, Editor Dafni Katsampa, personality disorders, psychotherapies, psychotherapy, randomised controlled trial, Structured Psychological Support (SPS), The Lancet Psychiatry, topicalBrief psychological support for ‘personality disorders’: no shortcut found
Individuals diagnosed with ‘personality disorders’, of which borderline personality disorder (BPD) is…
